IPAC2012 - List of Authors (Dorda, U.)

Paper	Title	Page
THPPR046	Status of the MedAustron Ion Beam Therapy Centre	4077
	U. Dorda CERN, Geneva, Switzerland M. Benedikt, A. Fabich, F. Osmic EBG MedAustron, Wr. Neustadt, Austria
	MedAustron is a synchrotron based light-ion beam therapy centre for cancer treatment as well as for clinical and non-clinical research currently in its construction phase. The accelerator design is based on the CERN-PIMMS study and its technical implementation by CNAO. This paper presents a status overview over the whole project detailing the achieved progress of the building construction & technical infrastructure installation in Wiener Neustadt, Austria, as well as of the accelerator development, performed at CERN and partially at PSI. The design and procurement status and future planning of the various accelerator components is elaborated.

THPPR052	The MedAustron Proton Gantry	4091
	A. Koschik PSI, Villigen, Switzerland U. Dorda, A. Koschik EBG MedAustron, Wr. Neustadt, Austria D. Meer, E.S. Pedroni Paul Scherrer Institut, Villigen, Switzerland
	The MedAustron project realizes a synchrotron based accelerator facility in Austria for cancer treatment with protons and carbon ions, currently in the construction phase. In order to allow full patient treatment flexibility, one of the four treatment rooms will be equipped with a proton gantry. While its hardware design is a copy of the PSI Gantry 2, different constraints on the beam optics must be accounted for as MedAustron uses a synchrotron as particle accelerator and a rotator to match the beam into the rotated frame, as compared to the cyclotron of the PSI PROSCAN facility. This paper presents the current status of the hardware design and procurement and a review of the design characteristics of the PSI Gantry 2 for the MedAustron case. In particular the stability of the beam parameters during beam scanning over the treatment scan area is investigated in detail. To achieve utmost parallel active scanning performance, the magnet design parameters (edge angles, corrector quadrupole, tapered dipole) have been optimized for PSI Gantry 2. Equivalent studies are undertaken for the MedAustron requirements and constraints in this paper.

Paper

Title

Page

Status of the MedAustron Ion Beam Therapy Centre

4077

U. Dorda
CERN, Geneva, Switzerland
M. Benedikt, A. Fabich, F. Osmic
EBG MedAustron, Wr. Neustadt, Austria

MedAustron is a synchrotron based light-ion beam therapy centre for cancer treatment as well as for clinical and non-clinical research currently in its construction phase. The accelerator design is based on the CERN-PIMMS study and its technical implementation by CNAO. This paper presents a status overview over the whole project detailing the achieved progress of the building construction & technical infrastructure installation in Wiener Neustadt, Austria, as well as of the accelerator development, performed at CERN and partially at PSI. The design and procurement status and future planning of the various accelerator components is elaborated.

THPPR052

The MedAustron Proton Gantry

4091

A. Koschik
PSI, Villigen, Switzerland
U. Dorda, A. Koschik
EBG MedAustron, Wr. Neustadt, Austria
D. Meer, E.S. Pedroni
Paul Scherrer Institut, Villigen, Switzerland

The MedAustron project realizes a synchrotron based accelerator facility in Austria for cancer treatment with protons and carbon ions, currently in the construction phase. In order to allow full patient treatment flexibility, one of the four treatment rooms will be equipped with a proton gantry. While its hardware design is a copy of the PSI Gantry 2, different constraints on the beam optics must be accounted for as MedAustron uses a synchrotron as particle accelerator and a rotator to match the beam into the rotated frame, as compared to the cyclotron of the PSI PROSCAN facility. This paper presents the current status of the hardware design and procurement and a review of the design characteristics of the PSI Gantry 2 for the MedAustron case. In particular the stability of the beam parameters during beam scanning over the treatment scan area is investigated in detail. To achieve utmost parallel active scanning performance, the magnet design parameters (edge angles, corrector quadrupole, tapered dipole) have been optimized for PSI Gantry 2. Equivalent studies are undertaken for the MedAustron requirements and constraints in this paper.